ZR2 BIOENERGY LIMITED
Fundamental Score
ZR2 BIOENERGY LIMITED Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of ZR2 across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Excellent EPS Growth (17.52% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.
Strong Profit Growth Track Record (20.48% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Balanced Promoter Holding (61.00%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
11 factors identified
Below-Average Return on Equity (0.09%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (0.21%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Premium Valuation Risk (P/E: 253.11x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.
Profit Decline Concern (-66.67%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.
Revenue Contraction (-100.00%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions and competitive positioning. Monitor recovery strategies.
Negative Free Cash Flow (₹-118.23 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
Limited Institutional Interest (FII+DII: 0.06%)
Observation: Low institutional participation may affect liquidity and visibility.
Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.
Very Low ROE
Observation: Poor capital utilization and shareholder returns.
Analysis: ROE below 5% suggests significant inefficiencies in capital deployment.
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
Very High P/E Ratio
Observation: Significant overvaluation risk present.
Analysis: Extremely high P/E ratios indicate potential bubble territory and high downside risk.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for ZR2 BIOENERGY LIMITED
About ZR2
Business Overview
ZR2 Bioenergy Limited operates as a bioenergy manufacturing company. It produces compressed biogas, ethanol, and potash. The company was formerly known as Gujchem Distillers India Limited and changed its name to ZR2 Bioenergy Limited May 2025. ZR2 Bioenergy Limited was founded in 1911 and is based in Mumbai, India.
Company Details
Key Leadership
Corporate Events
Latest News
ZR2 Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of ZR2 BIOENERGY LIMITED (ZR2)?
As of 30 Jan 2026, 01:35 pm IST, ZR2 BIOENERGY LIMITED (ZR2) is currently trading at ₹166.00. The stock has a market capitalization of ₹108.84 (Cr).
Is ZR2 share price Overvalued or Undervalued?
ZR2 is currently trading at a P/E ratio of 253.11x, compared to the industry average of 20.98x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.
What factors affect the ZR2 BIOENERGY LIMITED share price?
Key factors influencing ZR2's price include its quarterly earnings growth (Sales Growth: -100.00%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is ZR2 BIOENERGY LIMITED a good stock for long-term investment?
ZR2 BIOENERGY LIMITED shows a 5-year Profit Growth of 20.48% and an ROE of 0.09%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing.
How does ZR2 BIOENERGY LIMITED compare with its industry peers?
ZR2 BIOENERGY LIMITED competes with major peers in the Commodity Chemicals. Investors should compare ZR2's P/E of 253.11x and ROE of 0.09% against the industry averages to determine its competitive standing.
What is the P/E ratio of ZR2 and what does it mean?
ZR2 has a P/E ratio of 253.11x compared to the industry average of 20.98x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹253 for every ₹1 of annual earnings.
How is ZR2 performing according to Bull Run's analysis?
ZR2 has a Bull Run fundamental score of 20.2/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does ZR2 belong to?
ZR2 operates in the Commodity Chemicals industry. This classification helps understand the competitive landscape and sector-specific trends affecting ZR2 BIOENERGY LIMITED.
What is Return on Equity (ROE) and why is it important for ZR2?
ZR2 has an ROE of 0.09%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently ZR2 BIOENERGY LIMITED generates profits from shareholders' equity.
How is ZR2's debt-to-equity ratio and what does it indicate?
ZR2 has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is ZR2's dividend yield and is it a good dividend stock?
ZR2 offers a dividend yield of 0.03%, which means you receive ₹0.03 annual dividend for every ₹100 invested.
How has ZR2 grown over the past 5 years?
ZR2 has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth 20.48%, and EPS Growth 17.52%.
What is the promoter holding in ZR2 and why does it matter?
Promoters hold 61.00% of ZR2 shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is ZR2's market capitalization category?
ZR2 has a market capitalization of ₹109 crores, placing it in the Small-cap category.
How volatile is ZR2 stock?
ZR2 has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for ZR2?
ZR2 has a 52-week high of ₹N/A and low of ₹N/A.
What is ZR2's operating profit margin trend?
ZR2 has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is ZR2's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of -100.00% and YoY Profit Growth of -66.67%.
What is the institutional holding pattern in ZR2?
ZR2 has FII holding of 0.00% and DII holding of 0.06%. Significant institutional holding often suggests professional confidence in the stock.